Cell Therapy News/Articles, page-16781

You are assuming GG and SI are a team?

1. No way SI agreed to another member of the BoD's to be added, in an easy fashion. That member is connected to GG. It was a condition for a CR at $2.30 per share. GG and his mates are well in the red.
2. SI is now the lesser shareholder. GG has more shares (and growing).
3. GG purchased his chunk. SI has not handed over his hard earned. Big difference.
4. GG needs SI, how/why? He can fail at his attempts to gain FDA approval, on his own? Expert failure with SI? Less costly to fail without SI.
5. GG hasn't recently purchased his shares to take advantage of the current CEO's successes - that's for certain. I'm guessing he wants change to enable his investment to flourish. Either that, or it's not investing, it's donating.
6. Would you be surprised if the current BoDs secretly view Shareholder funds as donations? Really? Are you Australian?